The surgical and interventional treatment for Takayasu's arteritis
10.3760/cma.j.issn.1007-631X.2011.08.014
- VernacularTitle:大动脉炎的介入及外科治疗
- Author:
Bing CHEN
;
Hengxi YU
;
Jian ZHANG
;
Jianxin LI
;
Yongquan GU
;
Lixing QI
;
Yixia QI
;
Ying HUANG
;
Zongjun DONG
;
Zhonggao WANG
- Publication Type:Journal Article
- Keywords:
Arteritis;
Angiolplasty;
Artery bypass
- From:
Chinese Journal of General Surgery
2011;26(8):664-667
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate vascular surgery and interventional technique applied in Takayasu's arteritis. Methods Data of 26 patients of Takayasu's arteritis admitted between January 2006 and December 2009 were retrospectively analyzed. The sex ratio(M/F) was 1: 4. 2, age averaged at (27±15)y. There were 16 cases of type Ⅰ , 7 cases of type Ⅱ and 3 cases of type Ⅲ according to Lupi-Herrera classification. 25 patients received surgery including 16 patients undergoing pecutaneous transluminal angioplasty operations, 9 patients doing traditional bypass surgery, and one patient was treated conservatively. Results 23 case-times of percutaneous transluminal angioplasty (PTA) were performed in 16 patients, including 12 cases of balloon angioplasty and 4 cases of stent angioplasty. Four significantly stenotic and occluded carotid arteries were revascularized successfully in 5 patients. Thrombosis of the carotid artery was found in one patient after balloon angioplasty. There were 4 patients in which repeated PTA treatment up to a total of 11 times were needed to guarantee vessel patency. Open surgery succeeded in 9 patients, and clinical symptoms were relieved in all cases during peri-operative period. 22 patients were followed up for 12 -46 months,one patient died of cerebral hemorrhage 3 months post-operation, one patient was found pseudoaneurysm at anastomotic stoma, and 2 patients suffered from anastomotic restenosis.Conclusions Vascular surgery played important role in the therapy of Takayasu's arteritis. PTA can be used repeatedly. Surgical bypass operation is difficult in technology, and can be used in cases that fail to response to PTA or in patients with severe cerebral ischemia.
